An intelligent healthcare framework for hepatocellular carcinoma diagnosis based on aggregated learners from biomedical data utilising explainable artificial intelligence
Open Access
- 16 February 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
In recent days, biomedical data mining and machine learning (ML) technologies have transformed the healthcare sector, which utilises cutting-edge medical innovative tools to develop effective decision support systems for disease diagnosis and health informatics. Liver cancer (LC) is a major contributor to the global cancer problem. Incidence rates of this disease have improved in several countries in the past decades. As the main histological kind of LC, hepatocellular carcinoma (HCC) constitutes the large majority of LC diagnoses and deaths. HCC is one of the primary reasons for cancer occurrence and fatality. Initial diagnosis of HCC remains the main aim in improving the poor diagnosis of this type of LC. Recognising HCC at an initial stage is frequently related to improved treatment possibilities for patients with small and symptomless tumours. Several artificial intelligence (AI) methods are considered advanced methods for processing and handling composite multimodal data ranging from repetitive clinical variables to higher-resolution medical images. This paper presents a Hepatocellular Carcinoma Diagnosis based on an Aggregated Learners Utilising Explainable Artificial Intelligence (HCDAL-XAI) model from biomedical data. The primary purpose of the HCDAL-XAI model is to deliver an accurate detection model for initial diagnosis and efficient treatment of HCC using progressive methods. Initially, the data pre-processing step uses min-max normalisation. Furthermore, the HCDAL-XAI model employs an ensemble of a sparse autoencoder (SAE), gated recurrent unit (GRU), and deep belief network (DBN) for the classification process. Lastly, the explainable AI (XAI) model employs SHapley Additive exPlanations (SHAP) to enhance the reliability of AI methods by making their decision-making processes understandable to humans. The comparison analysis of the HCDAL-XAI methodology portrayed a greater accuracy value of 98.18% over existing models under the HCC dataset.Keywords
This publication has 36 references indexed in Scilit:
- Explainable deep learning model with the internet of medical devices for early lung abnormality detectionEngineering Applications of Artificial Intelligence, 2025
- Opportunistic Detection of Hepatocellular Carcinoma Using Noncontrast CT and Deep Learning Artificial IntelligenceJournal of the American College of Radiology, 2025
- Artificial intelligence in healthcare and medicine technology development reviewEngineering Applications of Artificial Intelligence, 2025
- Hepatocellular carcinoma recognition from ultrasound images with pixelated disparity based deep CNN based fire hawk optimizerBiomedical Signal Processing and Control, 2024
- Interpretable machine learning based on CT-derived extracellular volume fraction to predict pathological grading of hepatocellular carcinomaAbdominal Radiology, 2024
- Enhancing patient information performance in internet of things-based smart healthcare system: Hybrid artificial intelligence and optimization approachesEngineering Applications of Artificial Intelligence, 2024
- Improving hepatocellular carcinoma diagnosis using an ensemble classification approach based on Harris Hawks OptimizationHeliyon, 2023
- Prediction of hepatocellular carcinoma risk in patients with type-2 diabetes using supervised machine learning classification modelHeliyon, 2022
- Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C CirrhosisJAMA Network Open, 2020
- Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological SlidesHepatology, 2020